News
01-12-2011, 03:54 AM
Researchers at MIT and Brigham and Women's Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.
More... (http://www.news-medical.net/news/20110112/Targeted-delivery-of-cisplatin-prodrug-provides-safe-effective-prostate-cancer-therapy-in-vivo.aspx)
More... (http://www.news-medical.net/news/20110112/Targeted-delivery-of-cisplatin-prodrug-provides-safe-effective-prostate-cancer-therapy-in-vivo.aspx)